160 related articles for article (PubMed ID: 26468294)
1. Human MageB2 Protein Expression Enhances E2F Transcriptional Activity, Cell Proliferation, and Resistance to Ribotoxic Stress.
Peche LY; Ladelfa MF; Toledo MF; Mano M; Laiseca JE; Schneider C; Monte M
J Biol Chem; 2015 Dec; 290(49):29652-62. PubMed ID: 26468294
[TBL] [Abstract][Full Text] [Related]
2. Expression of the tumor-expressed protein MageB2 enhances rRNA transcription.
Ladelfa MF; Peche LY; Amato GE; Escalada MC; Zampieri S; Pascucci FA; Benevento AF; Do Porto DF; Dardis A; Schneider C; Monte M
Biochim Biophys Acta Mol Cell Res; 2021 Jun; 1868(7):119015. PubMed ID: 33741433
[TBL] [Abstract][Full Text] [Related]
3. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
[TBL] [Abstract][Full Text] [Related]
4. AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma.
Conteduca G; Fenoglio D; Parodi A; Battaglia F; Kalli F; Negrini S; Tardito S; Ferrera F; Salis A; Millo E; Pasquale G; Barra G; Damonte G; Indiveri F; Ferrone S; Filaci G
Oncotarget; 2016 Sep; 7(38):60872-60884. PubMed ID: 27563821
[TBL] [Abstract][Full Text] [Related]
5. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
[TBL] [Abstract][Full Text] [Related]
6. Cellular transformation of mouse embryo fibroblasts in the absence of activator E2Fs.
Gupta T; Sáenz Robles MT; Pipas JM
J Virol; 2015 May; 89(9):5124-33. PubMed ID: 25717106
[TBL] [Abstract][Full Text] [Related]
7. Melanoma antigen-D2: A nucleolar protein undergoing delocalization during cell cycle and after cellular stress.
Pirlot C; Thiry M; Trussart C; Di Valentin E; Piette J; Habraken Y
Biochim Biophys Acta; 2016 Apr; 1863(4):581-95. PubMed ID: 26705694
[TBL] [Abstract][Full Text] [Related]
8. Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1.
Penzo M; Massa PE; Olivotto E; Bianchi F; Borzi RM; Hanidu A; Li X; Li J; Marcu KB
J Cell Physiol; 2009 Jan; 218(1):215-27. PubMed ID: 18803232
[TBL] [Abstract][Full Text] [Related]
9. MDMX regulation of p53 response to ribosomal stress.
Gilkes DM; Chen L; Chen J
EMBO J; 2006 Nov; 25(23):5614-25. PubMed ID: 17110929
[TBL] [Abstract][Full Text] [Related]
10. Aberrant demethylation and expression of MAGEB2 in a subset of malignant peripheral nerve sheath tumors from neurofibromatosis type 1.
Nobeyama Y; Nakagawa H
J Dermatol Sci; 2016 Feb; 81(2):118-23. PubMed ID: 26642794
[TBL] [Abstract][Full Text] [Related]
11. The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiation.
Dilla T; Romero J; Sanstisteban P; Velasco JA
Oncogene; 2002 Apr; 21(15):2376-86. PubMed ID: 11948421
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma protein recruits histone deacetylase to repress transcription.
Brehm A; Miska EA; McCance DJ; Reid JL; Bannister AJ; Kouzarides T
Nature; 1998 Feb; 391(6667):597-601. PubMed ID: 9468139
[TBL] [Abstract][Full Text] [Related]
13. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
Ferreira R; Magnaghi-Jaulin L; Robin P; Harel-Bellan A; Trouche D
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10493-8. PubMed ID: 9724731
[TBL] [Abstract][Full Text] [Related]
14. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclin A kinase activity in E2F-1 chemogene therapy of colon cancer.
Elliott MJ; Baker JD; Dong YB; Yang HL; Gleason JF; McMasters KM
Tumour Biol; 2002; 23(6):324-36. PubMed ID: 12677090
[TBL] [Abstract][Full Text] [Related]
16. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents.
Monte M; Simonatto M; Peche LY; Bublik DR; Gobessi S; Pierotti MA; Rodolfo M; Schneider C
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11160-5. PubMed ID: 16847267
[TBL] [Abstract][Full Text] [Related]
17. Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions.
Gopal YN; Chanchorn E; Van Dyke MW
Mol Cancer Ther; 2009 Mar; 8(3):552-62. PubMed ID: 19276167
[TBL] [Abstract][Full Text] [Related]
18. MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription.
Laduron S; Deplus R; Zhou S; Kholmanskikh O; Godelaine D; De Smet C; Hayward SD; Fuks F; Boon T; De Plaen E
Nucleic Acids Res; 2004; 32(14):4340-50. PubMed ID: 15316101
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the Arf/p53 tumor surveillance network by E2F.
Iaquinta PJ; Aslanian A; Lees JA
Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767
[TBL] [Abstract][Full Text] [Related]
20. Cancer germline antigen gene MAGEB2 promotes cell invasion and correlates with immune microenvironment and immunotherapeutic efficiency in laryngeal cancer.
Cui J; Chen Y; Ou Y; Liu G; Wen Q; Zhu W; Liang L; Chen Z; Yang H; Wang L; Wei M
Clin Immunol; 2022 Jul; 240():109045. PubMed ID: 35618211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
